Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
C.H. Robinson reports after market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-04-29 | -$1.53 (-0.81%) | $4.51 (2.40%) | -$4.62 (-2.48%) | $10.49 (5.63%) |
| 2026-01-28 | +$3.85 (+2.14%) | $5.07 (2.81%) | +$9.44 (+5.12%) | $14.08 (7.64%) |
| 2025-10-29 | +$1.31 (+1.02%) | $4.27 (3.33%) | +$25.50 (+19.71%) | $9.48 (7.33%) |
| 2025-07-30 | -$2.14 (-2.14%) | $3.28 (3.29%) | +$17.67 (+18.10%) | $11.21 (11.48%) |
| 2025-04-30 | +$0.89 (+1.01%) | $2.51 (2.84%) | +$1.06 (+1.19%) | $5.52 (6.18%) |
| 2025-01-29 | -$1.89 (-1.72%) | $2.55 (2.32%) | -$7.49 (-6.94%) | $7.28 (6.75%) |
| 2024-10-30 | +$1.64 (+1.52%) | $2.70 (2.50%) | -$6.60 (-6.02%) | $8.09 (7.38%) |
| 2024-07-31 | -$0.29 (-0.32%) | $2.50 (2.80%) | +$13.16 (+14.78%) | $7.13 (8.01%) |
| Avg Abs Move | 1.34% | 2.79% | 9.29% | 7.55% |
CHRW's post-earnings price behavior has been highly volatile and directionally mixed, with an average absolute Day +1 move of 9.29%—well above typical single-stock earnings reactions. The most recent four reports show dramatic swings: the stock surged +19.71% the day after the October 2025 report and +18.10% following July 2025 earnings, but also fell sharply after other releases, including a -6.94% drop in January 2025 and a -6.02% decline in October 2024.
The Day 0 moves have been much more subdued, averaging just 1.34%, which is consistent with after-hours reporting—most of the price discovery happens the following session once investors digest the results and management commentary. The Day +1 range averages 7.55%, indicating that intraday volatility is also elevated, with the stock often gapping significantly at the open and then continuing to move throughout the session.
The pattern suggests that CHRW's earnings are high-stakes events where results and guidance can trigger large revaluations. The recent history of massive post-earnings rallies (July and October 2025) likely reflects the market repricing the stock higher as the freight recovery narrative gained credibility. Investors should be prepared for a wide range of outcomes—the stock could easily move 10% or more in either direction depending on whether the company beats, meets, or misses expectations, and whether management's commentary on the freight cycle and margin outlook is constructive or cautious.
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 24) |
| Expected Move | $15.43 (9.12%) |
| Expected Range | $153.78 to $184.64 |
| Implied Volatility | 50.52% |
The options market is pricing an expected move of 9.12% through the August 21 expiration, which aligns closely with the 9.29% average absolute Day +1 move observed in recent earnings reports. This suggests options traders are appropriately pricing in CHRW's historical post-earnings volatility, and the current implied move is neither unusually conservative nor aggressive relative to past behavior.
Analysts are decisively bullish on C.H. Robinson heading into earnings, with the consensus rating standing at 4.24 out of 5.00—firmly in Buy territory. The breakdown shows 16 Strong Buys, 1 Moderate Buy, 7 Holds, 0 Moderate Sells, and 1 Strong Sell among the 25 analysts covering the stock. This represents a 68% Strong Buy concentration, reflecting broad confidence in the freight recovery thesis and Robinson's ability to capitalize on improving industry conditions.
Sentiment has improved over the past month, with the average recommendation ticking up from 4.20 to 4.24. The shift was driven by one analyst upgrading from Hold to Strong Buy and another moving from Moderate Sell to Strong Sell (likely a bearish outlier), while the Strong Buy count increased from 15 to 16. The net effect is a more bullish tilt, suggesting analysts are gaining conviction as the earnings date approaches.
The average price target of $206.60 implies +22.0% upside from the current price of $169.34, which is substantial and reflects expectations that the stock will re-rate higher as earnings growth accelerates and the freight cycle matures. However, the wide range of targets—from a low of $91.00 to a high of $235.00—underscores the divergence of views on valuation and the sustainability of the recovery. The high target implies +38.8% upside, while the low target suggests -46.3% downside, highlighting the binary nature of the bull and bear cases. The concentration of bullish ratings and the meaningful implied upside suggest the Street is positioned for continued outperformance, but the wide target range also indicates that a disappointing result or cautious outlook could trigger a sharp reassessment.
C.H. Robinson enters earnings in a technically weakened state, with the stock trading at $169.34—below all major moving averages. The shares are below the 5-day MA ($188.63), 10-day MA ($197.01), 20-day MA ($194.57), 50-day MA ($186.68), 100-day MA ($179.74), and 200-day MA ($171.38). This configuration signals that the stock has been under sustained selling pressure across all timeframes, with short-term momentum particularly weak.
The Barchart Technical Opinion has deteriorated sharply, falling from 100% Buy a week ago to just 8% Buy currently, and down from 88% Buy a month ago. This dramatic shift reflects the recent breakdown in price action and suggests the technical picture has turned decisively negative heading into the report.
Timeframe Analysis:
Trend Characteristics: The trend is characterized by Minimum strength and the Weakest direction, indicating the stock is in a fragile technical state with little momentum support and vulnerable to further downside if earnings disappoint.
The stock is trading just $1.96 above the 200-day moving average, a critical long-term support level. A break below this level on a disappointing earnings reaction could trigger additional technical selling and open the door to a deeper correction. Conversely, a strong beat and bullish guidance could spark a sharp reversal, with the stock needing to reclaim the $186.68 (50-day MA) and then the $194.57 (20-day MA) to signal that the technical damage is being repaired. The overall setup is cautionary—the stock is oversold and due for a bounce, but the lack of technical support means earnings will likely be a high-volatility, make-or-break event that determines whether CHRW can stabilize or continues to deteriorate.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $188.63 | 50-Day MA | $186.68 |
| 10-Day MA | $197.01 | 100-Day MA | $179.74 |
| 20-Day MA | $194.57 | 200-Day MA | $171.38 |
Key resistance levels to watch include the 50-day MA at $186.68 and the 20-day MA at $194.57, both of which would need to be reclaimed to signal a meaningful technical recovery. On the downside, the 200-day MA at $171.38 is critical support—a decisive break below this level would confirm a longer-term downtrend and likely trigger additional selling. The overall technical setup is cautionary, with the stock entering earnings in a weakened state and vulnerable to further downside if results or guidance disappoint, though the oversold condition also creates potential for a sharp reversal if the company delivers a strong beat.